Related Experiment Videos
Kawasaki disease: a new disease?
1Japan Kawasaki Disease Research Center, Kubo Bldg., 1-1-1 Kandasuda-cho, Chiyoda-ku, Tokyo 101, Japan.
Acta Paediatrica Taiwanica = Taiwan Er Ke Yi Xue Hui Za Zhi
|March 29, 2001
Summary
Kawasaki disease (KD) remains a clinical entity due to its unknown cause. Further research into its etiology is needed to determine if KD is a distinct disease.
Area of Science:
- Pediatrics
- Rheumatology
- Infectious Diseases
Background:
- Kawasaki disease (KD) is a recognized clinical syndrome, but its underlying cause remains elusive.
- The classification of KD as a distinct disease entity is debated due to the unknown etiology.
- Key publications from 1999 by Long and Shulman are examined in the context of KD's classification.
Purpose of the Study:
- To analyze the current understanding of Kawasaki disease (KD) as a clinical versus disease entity.
- To review historical perspectives on KD classification based on its unknown etiology.
- To determine the criteria necessary for reclassifying KD as a definitive disease entity.
Main Methods:
- Literature review of seminal papers on Kawasaki disease (KD).
- Analysis of arguments regarding KD's classification as a clinical entity.
- Examination of the impact of etiological understanding on disease definition.
Main Results:
- Kawasaki disease (KD) is currently classified as a clinical entity, not a disease entity.
- The lack of a known cause prevents definitive classification.
- Historical medical literature supports the view that etiology dictates disease entity status.
Conclusions:
- Kawasaki disease (KD) cannot be definitively termed a disease entity until its etiology is discovered.
- Further etiological research is paramount for the accurate classification of KD.
- The definition of a disease entity hinges on understanding its causative agent.